It is estimated that 30%-50% of stage 5 CKD patients have PTH levels of >300 pg/mL [30]. Elevated PTH levels occur in response to hypocalcemia induced by phosphate retention and reduced calcitriol synthesis as a consequence of reduced renal function [31]. The gene discussed is PTH; the disease is chronic kidney disease.